Budapest, Hungary

Zolton Palmai

This inventor holds 1 USPTO granted patent. Top assignee: New Vision Co., Ltd.. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zolton Palmai. Retrieved from https://idiyas.com/inventor/zolton-palmai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zolton Palmai: Innovator in Cataract Treatment

Introduction

Zolton Palmai is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of ophthalmology, particularly in the treatment of cataracts. His innovative approach has the potential to change the lives of many patients suffering from this common eye condition.

Latest Patents

Zolton Palmai holds a patent for a method and composition for treating cataracts. This non-toxic pharmaceutical composition, when applied to a patient through intravenous injection on a consecutive daily basis, aims to dissolve cataracts and restore lost vision. The treatment is tailored based on the severity of the cataracts, offering a promising solution for those affected.

Career Highlights

Palmai's career is marked by his dedication to advancing medical treatments. His work at New Vision Co., Ltd. has positioned him as a key player in the development of innovative therapies for eye care. His commitment to research and development has led to breakthroughs that enhance patient outcomes.

Collaborations

Zolton Palmai collaborates with Gyula Nagy, a fellow professional in the field. Their partnership exemplifies the importance of teamwork in driving innovation and improving healthcare solutions.

Conclusion

Zolton Palmai's contributions to cataract treatment highlight his role as an inventor dedicated to improving patient care. His innovative methods and compositions represent a significant advancement in ophthalmology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…